The short-term release enters its first release candidate stage on August 6, with general availability set for September 15, as Oracle and the OpenJDK community lock in a nine-JEP feature set anchored ...
Oracle is urging customers to move from quarterly to monthly security patching, arguing that artificial intelligence is accelerating vulnerability discovery faster than traditional update schedules ...
Consultants say the functionality looks strong and it should be effective, but at the possible price of trading one vendor ...
JDK 27 will include a new default garbage collector and eight other features. A release candidate is due August 6.
India’s Sun Pharmaceutical Industries has received approval from South Africa’s health regulator to manufacture and sell a generic version of semaglutide, the active ingredient in Novo Nordisk’s ...
Download Oracle Java JDK to build, compile, debug, and run modern applications with a trusted development kit for Windows, macOS, and Linux. Access the compiler, runtime tools, libraries, ...
The Hikma Court correctly held that a generic manufacturer should not be liable for induced patent infringement if it carves patented uses out of its label. FDA can navigate Hikma’s aftermath without ...
Daniel covers the intersection of the health industry and the federal government. He reports on corporate influence in government, the health consequences of federal policies, and the politics of ...
Glenmark Pharmaceuticals (BSE: 532296) has launched a US generic version of Zyprexa (olanzapine) for injection, adding another hospital medicine to its growing injectables portfolio as the company ...
Share on Pinterest Federal regulators have agreed to review a Swiss pharmaceutical company’s applications for two cheaper generic versions of Zepbound and Mounjaro. MK Photo/Alamy Stock Photo Federal ...
Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Carley ...